Characteristics and Outcome of Patients With COVID-19 in ICUs in South Tyrol

Institute of Mountain Emergency Medicine550 enrolled

Overview

The investigators retrospectively investigate the epidemiology, clinical characteristics and therapeutic interventions of patients with COVID-19 associated respiratory failure admitted to the intensive care units in South Tyrol, Italy.

In this observational, retrospective study the epidemiology, characteristics, therapeutic interventions and outcome of patients with COVID-19 associated respiratory failure admitted to the intensive care units in South Tyrol, Italy, are assessed. Data extracted from the medical patients' records include type and duration of respiratory support (high-flow nasal oxygen, non-invasive ventilation, invasive ventilation), need for tracheostomy, vasopressor needs, antibiotic therapy, corticosteroid treatment, laboratory values (interleukin-6, C-reactive protein, procalcitonin, D-dimer, lymphocyte count), lengths of stay in the ICU and mortality.

Study Type

OBSERVATIONAL

Enrollment

550

Conditions

COVID-19 COVID-19 Acute Respiratory Distress Syndrome

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All patients admitted to the intensive care units in South Tyrol due to COVID-19 associated respiratory failure Exclusion Criteria: * SARS-CoV-2 patients admitted to the intensive care units in South Tyrol for other pathologies (i.e., not respiratory failure)

Locations (1)

Eurac research

Bolzano, Italy

Outcomes

Primary Outcomes

Mortality

Mortality (dead/alive) at discharge from the ICU is defined as primary outcome

Time frame: Through study completion, an average of 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.